Original Research
Published on 18 Feb 2020
Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2020.00076
- 8,027 views
- 20 citations
